GLP-1 Eligibility Checker
Check if you may qualify for GLP-1 weight loss medication based on FDA-approved criteria. Takes 30 seconds.
Do You Qualify for GLP-1 Weight-Loss Medication? (2026)
You likely qualify for FDA-approved GLP-1 weight-loss medication if your body mass index (BMI) is 30 or higher, or if your BMI is 27 or higher and you have at least one weight-related health condition. That second path covers conditions like type 2 diabetes, high blood pressure (hypertension), high cholesterol (dyslipidemia), obstructive sleep apnea, or cardiovascular disease. These are the exact criteria written into the FDA labels for Wegovy (semaglutide) and Zepbound (tirzepatide), the two drugs approved specifically for chronic weight management. The medication is approved for adults; Wegovy is also approved for children 12 and older with obesity. Eligibility on paper is not the same as a prescription, though. A licensed clinician confirms your BMI, reviews your health history, and rules out the safety conditions below before prescribing. Use the checker beneath this section to see where you land, then compare programs that can actually prescribe for your profile.
What BMI do you need to qualify for a GLP-1 like Wegovy or Zepbound?+
Which health conditions count toward qualifying at a BMI of 27 to 29.9?+
Who should NOT take GLP-1 weight-loss medication?+
Does meeting the BMI criteria guarantee I'll get a prescription?+
Is there a minimum age for GLP-1 weight-loss medication?+
Sources: Wegovy (semaglutide) FDA Prescribing Information, rev. 06/2026, Indications, Contraindications, Boxed Warning, Pancreatitis, Pregnancy · Zepbound (tirzepatide) FDA Prescribing Information, Indications, Contraindications, Acute Pancreatitis, Pregnancy · Zepbound (tirzepatide) Label on DailyMed (NIH/NLM) · FDA Press Announcement, FDA Approves New Medication for Chronic Weight Management (Zepbound)